BioAtla, Inc. (BCAB)
NASDAQ: BCAB · Real-Time Price · USD
2.000
-0.090 (-4.31%)
Nov 4, 2024, 4:00 PM EST - Market closed
BioAtla Employees
BioAtla had 65 employees as of December 31, 2023. The number of employees decreased by 1 or -1.52% compared to the previous year.
Employees
65
Change (1Y)
-1
Growth (1Y)
-1.52%
Revenue / Employee
n/a
Profits / Employee
-$1,608,554
Market Cap
96.67M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 65 | -1 | -1.52% |
Dec 31, 2022 | 66 | 10 | 17.86% |
Dec 31, 2021 | 56 | 20 | 55.56% |
Dec 31, 2020 | 36 | - | - |
Related Stocks
Company Name | Employees |
---|---|
FONAR | 561 |
Harvard Bioscience | 416 |
MDxHealth | 300 |
Adicet Bio | 143 |
OptiNose | 132 |
Assertio Holdings | 53 |
Regulus Therapeutics | 30 |
Relmada Therapeutics | 20 |
BCAB News
- 27 days ago - BioAtla's FDA Fast-Tracked Drug Candidate Boosts Its Oncology Prospects, Speculative Buy - Seeking Alpha
- 4 weeks ago - BioAtla: Numerous Catalysts Coming In Q4 - Seeking Alpha
- 4 weeks ago - BioAtla Announces Upcoming Poster Presentation at the 39th Society for Immunotherapy of Cancer Annual Meeting - GlobeNewsWire
- 4 weeks ago - BioAtla Announces Upcoming Oral Presentation at the Society for Melanoma Research 21st International Congress - GlobeNewsWire
- 6 weeks ago - BioAtla and Context Therapeutics Announce Exclusive Worldwide License Agreement to Develop and Commercialize BA3362, a Nectin-4 x CD3 T Cell Engaging Antibody - GlobeNewsWire
- 3 months ago - BioAtla, Inc. (BCAB) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - BioAtla Highlighted Clinical Program and Pipeline Updates at Virtual R&D Day - GlobeNewsWire
- 5 months ago - BioAtla to Participate in the Jefferies Global Healthcare Conference - GlobeNewsWire